Honda Electronics' ultrasonic microscope for cells

Honda Electronics' ultrasonic microscope for cells

Honda Electronics and Prof. Naohiro Hozumi of Toyohashi University of Technology have developed an ultrasonic microscope that can observe the state of cultured cells as a continuous tomogram, and will build a prototype for commercialization by December, followed by evaluation of the microscope at Hamamatsu University of Medicine. They aim to commercialize the microscope within four years after the evaluation. The aim is to use the microscope in regenerative medicine and drug discovery. The developed ultrasound microscope for cell observation incorporates software for acoustic analysis method developed at Toyohashi University of Technology. By using the acoustic analysis method, it is possible to view the fault information of living cells without touching the cell culture medium. Image taken on June 3, 2019, location unknown, credit: Nikkan Kogyo Shimbun / Kyodo News Images

  • Product Code
  • ILEA000687749
  • Registered date
  • 2019/6/03 00:00:00
  • Credit
  • THE NIKKAN KOGYO SHIMBUN / Kyodo News Images
  • Media source
  • THE NIKKAN KOGYO SHIMBUN
  • Media size
  • 3820 × 3164 pixel
  • Resolution
  • 144 dpi
  • Deployment size
  • 4.72(MB)*
  • Special instruction
  • **The text may be generated by an automatic translation system**

*File size when opened in Photoshop, etc.

Similar Images & Videos
    Shionogi's new mid-term management plan briefing

    Shionogi's new mid-term management plan briefing

    On the 1st, Shionogi announced a new mid-term management plan to invest 500 billion yen in expanding overseas business and launching new businesses by FY2024. The company will also increase research and development expenses by 20% over the past five years to about 342.1 billion yen. In addition to strengthening its own sales of pharmaceuticals in Japan and overseas, the company will also invest heavily in products and services other than ethical drugs, such as vaccines.In terms of sales strategy, the company plans to strengthen its sales in the U.S. and China, and increase the ratio of overseas sales to more than 50% in FY2012 (18.5% in FY2007). President Tedairogi said, "We aim to become a drug discovery company that people from outside the company want to work with," and also indicated that the company will place importance on alliance strategies. (Photo taken on June 1, 2020, location unknown, credit: Nikkan Kogyo Shimbun / Kyodo News Images)
      Tohoku University and TEPCO to conduct joint research on decommissioning

      Tohoku University and TEPCO to conduct joint research on decommissioning

      The term is five years. The division will conductresearch in a wide range of fields to solve various technical problems at the decommissioning site, including evaluation technology to detect the aging deterioration of structures. With the aim of fostering human resources, a CFReND branch office will be established at the Fukushima Daiichi Nuclear Power Plant site this summer. On-site exchanges of opinions between engineers at the decommissioning site and Tohoku University faculty and graduate students will be promoted. Nobuyoshi Hara, vice president of Tohoku University (photo at right), says, "We will continue our efforts to promote decommissioning. (Photo taken on March 24, 2020, location unknown, credit: Nikkan Kogyo Shimbun / Kyodo News Images)
        Professor Inoue of University of Tokyo, announce the identification of a new coronavirus drug candidate

        Professor Inoue of University of Tokyo, announce the identification of a new coronavirus drug candidate

        Professor Junichiro Inoue and his colleagues at the University of Tokyo's Institute of Medical Science held a press conference on April 18 and announced that they had identified nafamostat. Nafamostat has been used for more than 30 years in Japan, and early clinical trials are expected to be conducted. The clinical research is expected to start by the beginning of April in cooperation with the National Center for Global Health and Medicine and others. When the new corona infects humans, proteins on the surface of the virus and proteins on the surface of human cells bind to each other, causing the outer membrane of the virus to fuse with the membrane of human cells. As a result, ribonucleic acid (RNA), which is the genetic information of the new corona, enters the human cell, and the virus multiplies. (March 18, 2020, Yasuda Auditorium, The University of Tokyo, Bunkyo-ku, Tokyo; Credit: Nikkan Kogyo Shimbun / Kyodo News Images)
          University of Electro-Communications and Obayashi Corporation's diagnostic device for correcting blurred images

          University of Electro-Communications and Obayashi Corporation's diagnostic device for correcting blurred images

          Associate Professor Norihiro Koizumi of the University of Electro-Communications and Obayashi Corporation (Bunkyo-ku, Tokyo) have developed a device that uses artificial intelligence (AI) and robotic technology to correct blurring caused by the movement of organs and assist in taking clear images using ultrasound. It is expected that Obayashi Corporation will start selling this device in April 2022 at a price of tens of millions of yen, for use as a supplement to ultrasound diagnostic equipment. In the future, it is envisioned that cancer treatment using radiation or heavy particle beams will be carried out while observing in real time. It is expected that by obtaining images that pinpoint the location of organs, the beam can be accurately irradiated to the affected area. Image taken on December 19, 2019, credit: Nikkan Kogyo Shimbun / Kyodo News Images
            Perovskite solar cell device developed by Yamagata University

            Perovskite solar cell device developed by Yamagata University

            Professor Kenshi Sano and his team at Yamagata University have developed a perovskite solar cell with a structure called "reverse type" fabricated by a low-temperature formation process of 150 degrees C or lower. So far, the conversion efficiency of the low-temperature formation and inverse-type structure has been 17-19%, but using Yamagata University's organic EL manufacturing technology, they have confirmed a conversion efficiency of over 20%. Conventionally, solar cells have been fabricated using a high-temperature formation method called the "forward type," in which an electron transport layer (titania) is baked on top of a special transparent conductive film using a high-temperature process (approximately 500 degrees C). The research team at Yamagata University has been working on the inverse type device structure, which can reduce the process temperature. (Photo taken on May 23, 2019, location unknown, credit: Nikkan Kogyo Shimbun / Kyodo News Images)
              Concept Crawler Robot for Plant Inspection

              Concept Crawler Robot for Plant Inspection

              Nine robot-related companies in Minamisoma City, Fukushima Prefecture, havebegun development of a new plant inspection crawler-type robot. With the help of a 15 million yen subsidy from Fukushima Prefecture to strengthen the robot industry infrastructure, they began designing the robot in June and will complete a prototype in December. The goal is to complete the robot in 2008 and introduce it to plants and disaster response organizations in 2009. Takawa Seimitsu, Sakae Seisakusho, Takeru Software, Winding Fukushima, Kikuchi Seisakusho Minamisoma Plant, YUBITOMA, Hanazawa Giken, Kousakusho, and Shinko, all based in Minamisoma City, are participating in the development. 9 companies are members of the Minamisoma Robot Industry Council established by Fukushima Prefecture's third sector, Dream Support Minamisoma. . = April 24, 2019, location unknown, credit: Nikkan Kogyo Shimbun / Kyodo News Images